What is the appropriate management, including antiviral choice and renal‑adjusted dosing, for a 62‑year‑old patient with chronic kidney disease and cardiomegaly who presents with new neck rigidity ten days after a facial herpes simplex (or herpes zoster ophthalmicus) infection?

Management of Suspected Viral Encephalitis Following Facial Herpes Infection

Start intravenous acyclovir immediately at 10 mg/kg every 8 hours, with dose adjustment for chronic kidney disease, while urgently pursuing diagnostic workup including lumbar puncture and neuroimaging to confirm viral encephalitis. 1, 2

Immediate Antiviral Therapy

The development of neck rigidity 10 days after facial herpes infection raises urgent concern for HSV or VZV encephalitis, which requires immediate empirical treatment:

• Initiate IV acyclovir 10 mg/kg every 8 hours without waiting for diagnostic confirmation 1, 2
• Treatment should begin within 6 hours of admission or as soon as encephalitis is suspected, as delays beyond 48 hours significantly worsen outcomes (mortality increases from 8% to >70%) 1, 2
• For this 62-year-old patient with chronic kidney disease, mandatory dose adjustment is required to prevent acyclovir-induced crystalluria and obstructive nephropathy 1, 3

Renal-Adjusted Dosing Protocol

Given the patient's chronic kidney disease, follow this specific dosing algorithm 3:

• Creatinine clearance >50 mL/min: 10 mg/kg every 8 hours
• Creatinine clearance 25-50 mL/min: 10 mg/kg every 12 hours
• Creatinine clearance 10-25 mL/min: 10 mg/kg every 24 hours
• Creatinine clearance <10 mL/min: 5 mg/kg (50% dose) every 24 hours 3
• If on hemodialysis: Administer additional dose after each dialysis session 3

Critical caveat: Each dose must be infused slowly over 1 hour—never give rapid or bolus injection, as this dramatically increases nephrotoxicity risk 3. Monitor renal function frequently during treatment 1.

Duration and Diagnostic Confirmation

• Treatment duration: 14-21 days for HSV encephalitis 2
• For VZV encephalitis: 10-14 days 1, 4
• Obtain CSF PCR for HSV and VZV DNA urgently—this remains positive for several days after starting acyclovir, so delayed lumbar puncture does not preclude diagnosis 1, 2
• If initial CSF PCR is negative but clinical suspicion remains high, repeat CSF PCR 3-7 days later 2
• Consider brain MRI to identify temporal lobe involvement (HSV) or other patterns 1

Special Considerations for This Patient

Cardiomegaly implications: Ensure adequate hydration during acyclovir infusion to prevent crystalluria, but monitor carefully for fluid overload given cardiac disease 1, 3. The patient may require more frequent monitoring of fluid status.

VZV vs HSV distinction: If the original facial infection was herpes zoster ophthalmicus (dermatomal distribution), VZV encephalitis or vasculopathy is more likely 1, 4. However, acyclovir 10 mg/kg every 8 hours covers both pathogens adequately 1.

Monitoring and Escalation

• Urgent ICU assessment if declining consciousness for airway protection and management of raised intracranial pressure 1
• Monitor for treatment failure: if no improvement after 5-7 days despite appropriate dosing, consider acyclovir resistance (rare in immunocompetent patients) 5
• For acyclovir resistance: Switch to IV foscarnet 40 mg/kg three times daily or 60 mg/kg twice daily 5
• Obtain repeat CSF PCR at end of therapy—persistent positive result warrants continued treatment 2

Adjunctive Therapy Considerations

Corticosteroids remain controversial in HSV encephalitis 1, 4, 2. One retrospective study suggested benefit, but a definitive randomized trial is ongoing 1. Do not routinely add corticosteroids unless there is marked cerebral edema with brain shift or raised intracranial pressure 1. For VZV vasculopathy specifically, corticosteroids (prednisolone 60-80 mg daily for 3-5 days) have stronger rationale due to the inflammatory/vasculitic component 1, 4.

Common Pitfalls to Avoid

• Never delay acyclovir for diagnostic testing in a deteriorating patient—CSF can be obtained later 1, 2
• Never use standard dosing without checking renal function—this patient's CKD mandates dose adjustment 1, 3
• Never give acyclovir as rapid bolus or IM/subcutaneous injection—only slow IV infusion over 1 hour 3
• Do not stop treatment prematurely—minimum 14 days for HSV encephalitis even if clinical improvement occurs earlier 2